HHS Report Slams FDA’s Conflict of Interest Oversight
Public release date: 13-Jan-2009 - 42% were missing the required financial disclosures on the investigators. - Most often, the sponsors said the investigators could not be located or failed to…
Drug marketing techniques may be risking patient safety
Public release date: 2-Dec-2008 Analysis: What can we learn from drug marketing efficiency? With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever…
Roche ordered to pay $13M to users of acne drug – Accutane ( 2008 )
Public release date: 20-Nov-2008 ATLANTIC CITY, N.J. – A jury has ordered drugmaker Roche to pay nearly $13 million to three patients who claim they developed a chronic bowel disorder…
14 drugs identified as most urgently needing study for off-label use, Stanford professor says
Public release date: 24-Nov-2008 - quetiapine (brand name Seroquel), warfarin, escitalopram, risperidone and montelukast etc... STANFORD, Calif. — Physicians and policy-makers know that drugs are frequently prescribed to treat…
How drug companies covertly promote off-label drug use
Public release date: 27-Oct-2008 Off-label prescription of a drug is generally legal, but promotion of off-label uses by a drug manufacturer is illegal. In an article in this week's PLoS Medicine,…
News media often do not report potential sources of bias in medical research
Public release date: 30-Sep-2008 An analysis of news media coverage of medical studies indicates that news articles often fail to report pharmaceutical company funding and frequently refer to medications by…
New Study on Effects of Disclosing Financial Interests on Participation in Medical Research (2008)
Public release date: 2-Oct-2008 Baltimore, MD. - Knowing how an investigator is paid for running a research study surprisingly plays a small role in patients' willingness to take part…
Top-selling prescription drug mismarketed to women / Lipitor does not appear to be scientifically supported for large segments of the female population.
Public release date: 17-Sep-2008 Ithaca, N.Y. – September 17, 2008 – Lipitor has been the top-selling drug in the world and has accounted for over $12 billion in annual sales.…
Half of trials supporting FDA applications go unpublished
Public release date: 22-Sep-2008 Over half of all supporting trials for FDA-approved drugs remained unpublished 5 years after approval, says new research published in this week's PLoS Medicine. The…
Corruption - Fabricated Data
Highlights
Lethal or Unintended Side Effects
Medical Ethics
Medical Propaganda
Popular COPD treatment increases risk for cardiac events, cardiac death ” longer than one month increases the risk of cardiovascular death, heart attack or stroke by more than 50 percent “
Public release date: 23-Sep-2008 WINSTON-SALEM, N.C. – New research out of Wake Forest University School of Medicine shows that use of the most commonly prescribed once-a-day treatment for chronic obstructive…
Corruption - Fabricated Data
Highlights
Lethal or Unintended Side Effects
Medical Ethics
Medical Propaganda
Cholesterol-lowering drugs and the effect on muscle repair and regeneration
Public release date: 25-Sep-2008 HILTON HEAD, SC—Statins are powerful drugs that reduce "bad" cholesterol and thus cut the risk of a heart attack. While these medications offer tremendous benefits…
Expert urges FDA to take action to reduce BPA exposure (2008)
Public release date: 16-Sep-2008 MU studies have shown dangerous health effects with BPA exposure since 1997 COLUMBIA, Mo. – In the current issue of the Journal of the American Medical…
BPA - Bisphenol A
Corruption - Fabricated Data
Lethal or Unintended Side Effects
Medical Ethics
Medical Propaganda
FDA defends (BPA) plastic linked with health risks (2008)
Public release date: 16-Sep-2008 With scientists at odds over the safety of a chemical found in plastic baby bottles, metal cans and other food packaging, consumers got minimal…
Corruption - Fabricated Data
Ineffective Treatments
Lethal or Unintended Side Effects
Medical Ethics
Medical Propaganda
Anti-psychotic drug use in the elderly increases despite drug safety warnings ( 2008 ) – 70% of people receiving antipsychotic drugs lived in nursing homes
Public release date: 25-Aug-2008 Three regulatory warnings of serious adverse events slowed the growth of use of atypical antipsychotic drugs among elderly patients with dementia, but they did not…
Post-marketing studies finding adverse events in drugs used in children / Very rare serious adverse events are seldom defined during a study
Public release date: 2-Sep-2008 DURHAM, NC -- The Food and Drug Administration Modernization Act (FDAMA, 1997), designed to stimulate more drug safety studies in children, has resulted in more than…
Flu shot does not cut risk of death in elderly / no decrease in hospital admissions or all-cause mortality
Public release date: 26-Aug-2008 While influenza vaccination does provide protection against catching the flu, it does not have a major impact on death in the elderly, contrary…
Documentary Evidence Reveals Motives of Pharmaceutical “Seeding” Trials / pharmaceutical company framed a marketing effort as a clinical trial
Public release date: 17-Aug-2008 Clinical studies that are designed by pharmaceutical companies to promote use of their drugs are called "seeding" trials. While much has been written about the marketing…
Flu vaccine may not protect seniors well / Vaccine was totally ineffective
Public release date: 31-Jul-2008 SEATTLE—A Group Health study in the August 2 issue of The Lancet adds fuel to the growing controversy over how well the flu vaccine protects the…
Schering-Plough, Merck’s Vytorin misses study goal / no better than placebo and startled to see about 50 percent more new cancer cases and cancer deaths in patients
Public release date: 21-Jul-2008 In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of…
Drug “Innovation comes mainly from NIH-supported research in academic medical centers. The drug companies do almost no innovation.” – ( 2008 )
Public release date: 24-Jun-2008 New report: The truth about drug innovation New York, NY: A new report co-authored by Manhattan Institute senior fellow Benjamin Zycher, and Joseph DiMasi, and…
You must be logged in to post a comment.